Arcellx CFO Disposes $785,000 in Stock; Analysts Offer Mixed Signals on Anito-cel Progress
Arcellx Chief Financial Officer Michelle Gilson sold 11,291 shares of common stock on February 17, 2026, generating roughly $784,782 in proceeds across two trades. The transactions follow a January restricted stock unit exercise and come amid a flurry of analyst updates that reflect both optimism about preclinical safety signals for the company’s a…